A number of providers have assays that can detect the BRAF p.Val600Glu sequence variant from formalin-fixed paraffin-embedded (FFPE) tumor samples or slides using a variety of technologies, including polymerase chain reaction (PCR) with and without fluorescence monitoring, dideoxy sequencing, direct sequencing, and pyrosequencing:. This evidence concerns the gene BRAF and neoplasm.